Overview

Safety And Efficacy of Low Dose Oral Anticoagulants And Aspirin Therapy

Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
A prospective, randomized, longitudinal, open label, parallel group clinical trial was designed to compare the proportions of failure to reach INR target 2.5-3.5 with either: small dose warfarin (<5 mg/day) or phenindione (<100 mg/day), in high-risk pregnant and non-pregnant patients with bileaflet mechanical heart valve prosthesis.
Phase:
Phase 3
Details
Lead Sponsor:
Yasser Elnahas
Treatments:
Anticoagulants
Aspirin
Phenindione
Warfarin